[Eculizumab for atypical hemolytic uremic syndrome in newborn: a case report] [0.03%]
新生儿用依库珠单抗治疗非典型溶血性尿毒综合征1例报告
Yara María Alonso-Triana,M J Perrino
Yara María Alonso-Triana
[Applying dose banding to the production of antineoplastic drugs: a narrative review of the literature] [0.03%]
[门控剂量在抗肿瘤药物配置中的应用：文献综述]
Pablo Pérez Huertas,Margarita Cueto Sola,Paloma Escobar Cava et al.
Pablo Pérez Huertas et al.
The dosage of antineoplastic drugs has historically been based on individualized prescription and preparation according to body surface area or patient´s weight. Lack of resources and increased assistance workload in the areas where chemot...
Sara Santana Martínez,José Antonio Marcos Rodríguez,Elia Romero Carreño
Sara Santana Martínez
Introduction: oral chemotherapy is increasingly used in Oncology. It has important advantages. such as patient comfort. but it also brings new challenges which did not exist with the intravenous therapy. Some of these dru...
[The impact of Pharmacy Intervention on the treatment of elderly multi-pathological patients] [0.03%]
药学干预对老年共病患者治疗的影响
Eva Delgado Silveira,Elia María Fernandez-Villalba,María García-Mina Freire et al.
Eva Delgado Silveira et al.
Objective: to analyze the impact of Pharmacy Intervention (PI), within the healthcare team who manages elderly multi-pathological patients, regarding the evolution of Drug Related Problems (DRPs) and Negative Outcomes Ass...
Ramón Morillo Verdugo,Javier Sáez de la Fuente,Miguel Ángel Calleja Hernandez
Ramón Morillo Verdugo
[Fatal Outcome for subcutaneous administration of Pegylated IFN alpha 2b in a man with Chronic C hepatitis under treatment with traditional bitherapy] [0.03%]
慢性丙型肝炎男性患者在接受传统二联疗法过程中皮下注射聚乙二醇干扰素α-2b的致命后果
Andrea Domínguez Gozalo,Francisco J Hidalgo Correas,Elena García Benayas et al.
Andrea Domínguez Gozalo et al.
[Nab-Paclitaxel plus gemcitabine in patients with metastatic pancreatic adenocarcinoma: experience of use] [0.03%]
[纳米白蛋白紫杉醇联合吉西他滨治疗转移性胰腺腺癌的临床应用经验]
Elena Ferris Villanueva,Mónica Martínez Penella,Pablo Cerezuela Fuentes et al.
Elena Ferris Villanueva et al.
Objective: To evaluate the results obtained with the combined use of nab-paclitaxel and gemcitabine in the treatment of patients with metastatic pancreatic adenocarcinoma. ...
Off-label and unlicensed utilization of drugs in a Brazilian pediatric hospital [0.03%]
巴西一家儿童医院中药品的超适应症使用及未获批使用情况研究
Vanessa Pereira Gomes,Kédma Melo da Silva,Suely Oliveira Chagas et al.
Vanessa Pereira Gomes et al.
Aim: To describe the off-label and unlicensed utilization patterns of drugs in a Brazilian pediatric hospital. Methods: The research co...
Trastuzumab emtansine in locally advanced or metastatic HER2 positive breast cancer; GENESIS-SEFH drug evaluation report [0.03%]
局部晚期或转移性HER2阳性乳腺癌中的trastuzumab emtansine治疗；GENESIS-SEFH药物评估报告
Patricia Miranda Romero,Roberto Marín Gil
Patricia Miranda Romero
Trastuzumab emtansina (T-DM1) is an antibody-drug conjugate directed against the HER2 for the treatment of HER2+ mestastatic breast cancer (MBC), who has previously received trastuzumab plus a taxane. According to the results of the EMILIA ...
[Cost-effectiveness analysis of Belimumab in patients with systemic lupus erythematosus in Spain] [0.03%]
贝利木单抗治疗西班牙系统性红斑狼疮患者的成本效益分析
Silvia Díaz-Cerezo,Ángel María García-Aparicio,Javier Parrondo et al.
Silvia Díaz-Cerezo et al.
Objective: To estimate the cost-effectiveness of belimumab in patients with systemic lupus erythematosus (SLE) presenting positive biomarkers and active disease despite standard treatment (ST), from the Spanish social per...